Volume 18, Issue 1, Pages 29-34 (January 2016) Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database Valery Vilchez, Malay B. Shah, Michael F. Daily, Luis Pena, Ching-Wei D. Tzeng, Daniel Davenport, Peter J. Hosein, Roberto Gedaly, Erin Maynard HPB Volume 18, Issue 1, Pages 29-34 (January 2016) DOI: 10.1016/j.hpb.2015.10.001 Copyright © 2015 Terms and Conditions
Figure 1 Patients transplanted for primary liver malignancy in UNOS database since 1994 to 2013. Out of 4049 patients, 94, 3515 and 440 have been transplanted for HCC-CC, HCC and CC, respectively. Liver primary malignancy as an indication of liver transplantation has increased since 2002, when the MELD score was implemented. Only 5 patients with HCC-CC where transplanted before 2002 HPB 2016 18, 29-34DOI: (10.1016/j.hpb.2015.10.001) Copyright © 2015 Terms and Conditions
Figure 2 (a) Patient survival after liver transplantation for mixed hepatocellular and cholangiocarcinoma. (b) Patient survival after liver transplantation for mixed hepatocellular and cholangiocarcinoma vs. hepatocellular carcinoma and cholangiocarcinoma. (c) Graft survival after liver transplantation for mixed hepatocellular and cholangiocarcinoma vs. hepatocellular carcinoma and cholangiocarcinoma HPB 2016 18, 29-34DOI: (10.1016/j.hpb.2015.10.001) Copyright © 2015 Terms and Conditions